TGFB1 and glioblastoma: In support of this idea, exogenous VEGF treatment prevents TGF-β-induced EndoMT during cardiac fibrosis (Illigens et al., 2017) and VEGFR2 expression is reduced in glioblastoma vessels alongside EndoMT program activation and acquired mesenchymal marker expression (Liu et al., 2018).